Prostate cancer is the second most common cancer in men globally and the fifth leading cause of cancer-related death, according to GLOBOCAN 2022 data published in CA: A Cancer Journal for Clinicians. Yet a growing body of peer-reviewed research suggests that dietary patterns adopted consistently over years can meaningfully influence risk, progression, and outcomes, not through miracle foods, but through cumulative biological effects on inflammation, hormones, and cellular behaviour.
Here is what the current science actually supports, presented without supplement industry framing.
The strongest evidence backs whole dietary patterns rather than individual ingredients. Plant-based diets rich in fruits, vegetables, whole grains, and healthy fats have demonstrated protective effects against prostate conditions including benign prostatic hyperplasia, prostatitis, and prostate cancer, while diets high in saturated fats and processed foods are associated with increased risk. The Mediterranean diet, built on olive oil, legumes, fish, and abundant vegetables, is among the most studied patterns in this context, with its anti-inflammatory and antioxidant properties thought to underlie its observed protective effects.
Specific bioactive compounds including lycopene, omega-3 fatty acids, and polyphenols have been linked to reduced disease progression across multiple studies. Lycopene, the red pigment found in tomatoes, watermelon, and guava, has attracted particular scientific interest. It inhibits androgen receptor expression in prostate cancer cells and reduces prostate cancer cell proliferation in laboratory studies, and its absorption is enhanced when consumed alongside dietary fat. However, human clinical trials have produced inconsistent findings, and researchers caution against interpreting laboratory results as clinical proof.
On omega-3 fatty acids, a large-scale 2025 study published in Frontiers in Nutrition, drawing on data from 30,552 male participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO), found that as omega-3 fatty acid intake increases, the risk of prostate cancer and prostate cancer death gradually decreases, with the lowest mortality risk corresponding to a daily intake of approximately 0.15 to 0.40 grams. The researchers noted that omega-3 compounds, specifically eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA), may work by inhibiting pro-inflammatory pathways and regulating cell death processes. Fatty fish including salmon, sardines, and mackerel are the richest dietary sources.
Green tea, broccoli, soy isoflavones, pomegranate, and curcumin from turmeric have also demonstrated measurable effects in clinical trials on prostate-specific antigen (PSA) levels and related hormonal markers, though researchers note that results remain inconclusive due to small sample sizes and varied study designs. Larger, more standardised trials are needed before firm clinical recommendations can be made on any individual food.
What the evidence does not support is equally important. No food or supplement has been shown to cure or reliably prevent prostate cancer. The United States National Cancer Institute’s clinical review of nutrition and prostate cancer, updated in late 2024, concludes that while many dietary compounds show promise in laboratory and population studies, human trials have consistently yielded mixed results that preclude firm dosage or dietary recommendations.
The practical implication of the collective evidence is straightforward: a diverse, plant-centred diet with regular servings of fatty fish, cooked tomato-based foods, and minimal processed meat and saturated fat represents the most defensible dietary approach for long-term prostate health. It is also a diet the cardiovascular, metabolic, and gastrointestinal evidence strongly endorses for entirely separate reasons.
Men with prostate health concerns should consult a qualified physician or registered dietitian before making significant dietary changes, and should treat any commercial product claiming to target prostate health with appropriate scepticism.
